Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
Go back to Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors| (NYSE: ANRO) | Delayed: 25.69 +2.76 (12.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.93 | 52 Week High | $ | |||
| Open | $22.32 | 52 Week Low | $ | |||
| Day High | $25.80 | P/E | N/A | |||
| Day Low | $22.32 | EPS | $ | |||
| Volume | 197,503 | |||||

